Table of Contents

July 2010; Volume 51,Issue 7

  1. Abrahmsen, Lars

    1. Targeting of HER2-Expressing Tumors Using 111In-ABY-025, a Second-Generation Affibody Molecule with a Fundamentally Reengineered Scaffold
      Sara Ahlgren, Anna Orlova, Helena Wållberg, Monika Hansson, Mattias Sandström, Richard Lewsley, Anders Wennborg, Lars Abrahmsén, Vladimir Tolmachev and Joachim Feldwisch
      Journal of Nuclear Medicine July 1, 2010, 51 (7) 1131-1138; DOI: https://doi.org/10.2967/jnumed.109.073346

  2. Ahlgren, Sara

    1. Targeting of HER2-Expressing Tumors Using 111In-ABY-025, a Second-Generation Affibody Molecule with a Fundamentally Reengineered Scaffold
      Sara Ahlgren, Anna Orlova, Helena Wållberg, Monika Hansson, Mattias Sandström, Richard Lewsley, Anders Wennborg, Lars Abrahmsén, Vladimir Tolmachev and Joachim Feldwisch
      Journal of Nuclear Medicine July 1, 2010, 51 (7) 1131-1138; DOI: https://doi.org/10.2967/jnumed.109.073346

  3. Amro, Hanan

    1. 131I-Tositumomab Radioimmunotherapy: Initial Tumor Dose–Response Results Using 3-Dimensional Dosimetry Including Radiobiologic Modeling
      Yuni K. Dewaraja, Matthew J. Schipper, Peter L. Roberson, Scott J. Wilderman, Hanan Amro, Denise D. Regan, Kenneth F. Koral, Mark S. Kaminski and Anca M. Avram
      Journal of Nuclear Medicine July 1, 2010, 51 (7) 1155-1162; DOI: https://doi.org/10.2967/jnumed.110.075176

  4. Anagnostopoulos, Constantinos

    1. Attenuation of Adenosine-Induced Myocardial Perfusion Heterogeneity by Atenolol and Other Cardioselective β-Adrenoceptor Blockers: A Crossover Myocardial Perfusion Imaging Study
      Eliana Reyes, James Stirrup, Michael Roughton, Savio D'Souza, S. Richard Underwood and Constantinos Anagnostopoulos
      Journal of Nuclear Medicine July 1, 2010, 51 (7) 1036-1043; DOI: https://doi.org/10.2967/jnumed.109.073411

  5. Anderson, Anne-Line

    1. Monodispersed DOTA-PEG–Conjugated Anti-TAG-72 Diabody Has Low Kidney Uptake and High Tumor-to-Blood Ratios Resulting in Improved 64Cu PET
      Lin Li, Fabio Turatti, Desiree Crow, James R. Bading, Anne-Line Anderson, Erasmus Poku, Paul J. Yazaki, Lawrence E. Williams, Debra Tamvakis, Paul Sanders, David Leong, Andrew Raubitschek, Peter J. Hudson, David Colcher and John E. Shively
      Journal of Nuclear Medicine July 1, 2010, 51 (7) 1139-1146; DOI: https://doi.org/10.2967/jnumed.109.074153

  6. Ashworth, Sharon

    1. Evaluation of 11C-GSK189254 as a Novel Radioligand for the H3 Receptor in Humans Using PET
      Sharon Ashworth, Eugenii A. Rabiner, Roger N. Gunn, Christophe Plisson, Alan A. Wilson, Robert A. Comley, Robert Y.K. Lai, Antony D. Gee, Marc Laruelle and Vincent J. Cunningham
      Journal of Nuclear Medicine July 1, 2010, 51 (7) 1021-1029; DOI: https://doi.org/10.2967/jnumed.109.071753

  7. Avram, Anca M.

    1. 131I-Tositumomab Radioimmunotherapy: Initial Tumor Dose–Response Results Using 3-Dimensional Dosimetry Including Radiobiologic Modeling
      Yuni K. Dewaraja, Matthew J. Schipper, Peter L. Roberson, Scott J. Wilderman, Hanan Amro, Denise D. Regan, Kenneth F. Koral, Mark S. Kaminski and Anca M. Avram
      Journal of Nuclear Medicine July 1, 2010, 51 (7) 1155-1162; DOI: https://doi.org/10.2967/jnumed.110.075176

  8. Azure, Michael

    1. Molecular Imaging of Matrix Metalloproteinase Activation to Predict Murine Aneurysm Expansion In Vivo
      Mahmoud Razavian, Jiasheng Zhang, Lei Nie, Sina Tavakoli, Niema Razavian, Lawrence W. Dobrucki, Albert J. Sinusas, D. Scott Edwards, Michael Azure and Mehran M. Sadeghi
      Journal of Nuclear Medicine July 1, 2010, 51 (7) 1107-1115; DOI: https://doi.org/10.2967/jnumed.110.075259

  9. Bading, James R.

    1. Monodispersed DOTA-PEG–Conjugated Anti-TAG-72 Diabody Has Low Kidney Uptake and High Tumor-to-Blood Ratios Resulting in Improved 64Cu PET
      Lin Li, Fabio Turatti, Desiree Crow, James R. Bading, Anne-Line Anderson, Erasmus Poku, Paul J. Yazaki, Lawrence E. Williams, Debra Tamvakis, Paul Sanders, David Leong, Andrew Raubitschek, Peter J. Hudson, David Colcher and John E. Shively
      Journal of Nuclear Medicine July 1, 2010, 51 (7) 1139-1146; DOI: https://doi.org/10.2967/jnumed.109.074153

  10. Behe, Martin

    1. Exendin-4–Based Radiopharmaceuticals for Glucagonlike Peptide-1 Receptor PET/CT and SPECT/CT
      Damian Wild, Andreas Wicki, Rosalba Mansi, Martin Béhé, Boris Keil, Peter Bernhardt, Gerhard Christofori, Peter J. Ell and Helmut R. Mäcke
      Journal of Nuclear Medicine July 1, 2010, 51 (7) 1059-1067; DOI: https://doi.org/10.2967/jnumed.110.074914
« Previous (Pages : 1 2 3 4 5 6 ... 18) Next »
Back to top

In this issue